Viewing Study NCT05239169


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2025-12-24 @ 10:50 PM
Study NCT ID: NCT05239169
Status: COMPLETED
Last Update Posted: 2025-05-01
First Post: 2021-12-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module